limpidity

PrepTutorEJDIC

[Injectable hospital preparation of valine labeled with the carbon 13 and nitrogen 15 (5 mg/mL) for a clinical trial on the brain tumor metabolism: Pharmaceutical control of active pharmaceutical ingredient and stability study of the finished product].

Tall ML1, Diouf E2, Filali S2, Sauvinet V3, Laleye D2, Dhelens C2, Salmon D4, Gabert L3, Nugue G5, Sandre-Balester C6, Berger F6, Pirot F4, Pivot C2.
Annales pharmaceutiques françaises.Ann Pharm Fr.2015 Sep;73(5):361-77. doi: 10.1016/j.pharma.2015.02.002. Epub 2015 Mar 5.
INTRODUCTION: The L-Valine labeled (L-[U-(13)C,(15)N] Val) is a stable isotopic tracer administered by parenteral route within the framework of a new clinical research program concerning the brain tumor metabolism. To meet regulatory requirements and have ready to use solution with an expiration dat
PMID 25747724

[Aseptic process validation and stability study of an injectable preparation of fructose (5%)-glycerol (10%) as part of a hospital clinical research program on endoscopic curative treatment for early epithelial neoplastic lesions of the gastrointestinal tract].

Tall ML1, Salmon D2, Diouf E3, Drai J4, Filali S3, Lépilliez V5, Pioche M5, Laleye D3, Dhelens C3, Ponchon T5, Pivot C3, Pirot F2.
Annales pharmaceutiques françaises.Ann Pharm Fr.2015 Mar;73(2):139-49. doi: 10.1016/j.pharma.2014.09.002. Epub 2014 Oct 16.
INTRODUCTION: As part of a hospital clinical research program on endoscopic curative treatment for early epithelial neoplastic lesions of the gastrointestinal tract, a new hospital sterile and non-pyrogenic preparation of fructose (5%)-glycerol (10%) was realized. Under pharmaceutical legislation, t
PMID 25745945

[Injectable preparation of labeled leucine with the carbon 13 for a clinical research program on the Alzheimer disease: pharmaceutical control of raw materials and the finished product and stability study].

Tall ML1, Lehmann S2, Diouf E3, Gérard C3, Filali S3, Gabelle A2, Hirtz C2, Gabert L4, Sauvinet V4, Pirot F5, Pivot C3.
Annales pharmaceutiques françaises.Ann Pharm Fr.2015 Jan;73(1):43-59. doi: 10.1016/j.pharma.2014.06.002. Epub 2014 Jul 11.
INTRODUCTION: The L-leucine labeled (L-[U-(13)C] Leu) is a stable isotopic tracer administered by parenteral route within the framework of a new clinical research program concerning the diagnosis of the Alzheimer's disease. To meet regulatory requirements and have ready to use solution with an expir
PMID 25577016

ADDITION OF SODIUM HYDROXIDE TO SERUM FOR THE COLORIMETRIC DETERMINATION OF ITS EVANS BLUE CONCENTRATION